These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21041002)

  • 1. Clinical significance of residual occult malignancy in thyroid carcinoma.
    Turanli S; Aslan S; Cetin A
    Am J Otolaryngol; 2011; 32(5):398-401. PubMed ID: 21041002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Completion thyroidectomy in patients with thyroid cancer who initially underwent unilateral operation.
    Kim ES; Kim TY; Koh JM; Kim YI; Hong SJ; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):145-8. PubMed ID: 15212657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of completion thyroidectomy following unilateral lobectomy for well-differentiated thyroid cancer.
    Kupferman ME; Mandel SJ; DiDonato L; Wolf P; Weber RS
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1209-12. PubMed ID: 12169901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving postoperative recurrence rates for carcinoma of the thyroid gland.
    McHenry C; Jarosz H; Lawrence AM; Paloyan E
    Surg Gynecol Obstet; 1989 Nov; 169(5):429-34. PubMed ID: 2814754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.
    Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S
    World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and predictive factors of malignancy in residual thyroid tissue and cervical lymph nodes after partial thyroidectomy for differentiated thyroid cancer.
    Alzahrani AS; Al Mandil M; Chaudhary MA; Ahmed M; Mohammed GE
    Surgery; 2002 Apr; 131(4):443-9. PubMed ID: 11935135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Differentiated thyroid carcinoma in children and adolescents: therapeutic strategy according to clinic presentation].
    Causeret S; Lifante JC; Borson-Chazot F; Varcus F; Berger N; Peix JL
    Ann Chir; 2004; 129(6-7):359-64. PubMed ID: 15297226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
    Grigsby PW; Reddy RM; Moley JF; Hall BL
    Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is the timing of completion thyroidectomy for differentiated thyroid carcinoma prognostic significant?].
    Walgenbach S; Junginger T
    Zentralbl Chir; 2002 May; 127(5):435-8. PubMed ID: 12058304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
    La Quaglia MP; Black T; Holcomb GW; Sklar C; Azizkhan RG; Haase GM; Newman KD
    J Pediatr Surg; 2000 Jun; 35(6):955-9; discussion 960. PubMed ID: 10873043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].
    Lin YK; Sheng JM; Zhao WH; Wang WB; Yu XF; Teng LS; Ma ZM
    Zhonghua Wai Ke Za Zhi; 2009 Mar; 47(6):450-3. PubMed ID: 19595234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
    Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
    Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
    Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
    Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reoperative thyroid surgery.
    Levin KE; Clark AH; Duh QY; Demeure M; Siperstein AE; Clark OH
    Surgery; 1992 Jun; 111(6):604-9. PubMed ID: 1595056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifocality of thyroid carcinomas: a "privilege" of papillary tumors or not?
    Papageorgiou MS; Liratzopoulos N; Efremidou EI; Karanikas M; Minipoulos G; Manolas KJ
    G Chir; 2010; 31(1-2):20-3. PubMed ID: 20298661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
    Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
    Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.